Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in Patients with Migraine

Overview

Journal J Headache Pain

Publisher Biomed Central

Date 2015 Nov 25

PMID 26596588

Citations 138

Authors

Jong-Geun Seo

Sung-Pa Park

Affiliations

Soon will be listed here.

Abstract

Background: Psychiatric problems have been commonly reported in patients with migraine. This study investigated the reliability and validity of the Generalized Anxiety Disorder-7 (GAD-7) and Generalized Anxiety Disorder-2 (GAD-2) in patients with migraine.

Methods: Subjects were recruited from a headache clinic and a neuropsychologist examined their GAD using the Mini International Neuropsychiatric Interview-Plus Version 5.0.0 (MINI). Subjects completed several instruments, including the GAD-7, the Beck Anxiety Inventory (BAI), the Migraine Disability Assessment Scale (MIDAS), the Headache Impact Test-6 (HIT-6), and the Migraine-Specific Quality of Life (MSQoL).

Results: Among 146 participants, 32 patients (21.9 %) had GAD as determined by the MINI. Cronbach's α for the GAD-7 and GAD-2 were 0.915 and 0.820, respectively. At a cutoff score of 5, the GAD-7 had a sensitivity of 78.1 %, a specificity of 74.6 %, a positive predictive value (PPV) of 46.3 %, and a negative predictive value (NPV) of 92.4 %. At a cutoff score of 1, the GAD-2 had a sensitivity of 84.4 %, a specificity of 72.8 %, a PPV of 46.6 %, and a NPV of 94.3 %. The scores of the GAD-7 and GAD-2 well correlated with the BAI score, the MIDAS score, the HIT-6 score, and the MSQoL score.

Conclusions: The GAD-7 and GAD-2 are both reliable and valid screening instruments for GAD in patients with migraine.

Citing Articles

Association of Longitudinal Trajectories of Physical Frailty With Dementia Status in Older Adults: A National Cohort Study.

Ye F, Zhou W, Pu J, Chen H, Wang X, Lee J Int J Geriatr Psychiatry. 2025; 40(2):e70051.

PMID: 39900556 PMC: 11790523. DOI: 10.1002/gps.70051.

Therapeutic Potential of Social Chatbots in Alleviating Loneliness and Social Anxiety: Quasi-Experimental Mixed Methods Study.

Kim M, Lee S, Kim S, Heo J, Lee S, Shin Y J Med Internet Res. 2025; 27:e65589.

PMID: 39808786 PMC: 11775481. DOI: 10.2196/65589.

Factorial Invariance of Scores on the Inner Wealth Inventory: A Nation-Wide Sample of Adults in the United States.

Kalkbrenner M, Zackery S, Zhao Y Unknown. 2024; 14(2):198-211.

PMID: 39717693 PMC: 11665273. DOI: 10.15241/mtk.14.2.198.

The Moderating Effect of Resilience on the Relationship Between the Relevance to Victims With Post-Trauma Psychiatric Symptoms of Community Residents After Seoul Halloween Crowd Crush.

Kim S, Jung S, Lee M, Oh K, Shin Y, Shin D Psychiatry Investig. 2024; 21(11):1183-1192.

PMID: 39610229 PMC: 11611461. DOI: 10.30773/pi.2024.0154.

Association between bullying victimization and mental health problems among Chinese left-behind children: a cross-sectional study from the adolescence mental health promotion cohort.

Feng Y, Zhang S, Liao X, Jia Y, Yang Y, Zhang W Front Psychiatry. 2024; 15:1440821.

PMID: 39575193 PMC: 11578976. DOI: 10.3389/fpsyt.2024.1440821.

References

Beghi E, Bussone G, DAmico D, Cortelli P, Cevoli S, Manzoni G . Headache, anxiety and depressive disorders: the HADAS study. J Headache Pain. 2010; 11(2):141-50. PMC: 3452290. DOI: 10.1007/s10194-010-0187-2. View

McWilliams L, Goodwin R, Cox B . Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain. 2004; 111(1-2):77-83. DOI: 10.1016/j.pain.2004.06.002. View

Garcia-Campayo J, Zamorano E, Ruiz M, Pardo A, Perez-Paramo M, Lopez-Gomez V . Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. Health Qual Life Outcomes. 2010; 8:8. PMC: 2831043. DOI: 10.1186/1477-7525-8-8. View

Lanteri-Minet M, Radat F, Chautard M, Lucas C . Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management. Pain. 2005; 118(3):319-326. DOI: 10.1016/j.pain.2005.09.010. View

Kroenke K, Spitzer R, Williams J, Monahan P, Lowe B . Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007; 146(5):317-25. DOI: 10.7326/0003-4819-146-5-200703060-00004. View

Seo J, Park S . Validation of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with migraine. J Headache Pain. 2015; 16:65. PMC: 4501946. DOI: 10.1186/s10194-015-0552-2. View

Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A . The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007; 27(3):193-210. DOI: 10.1111/j.1468-2982.2007.01288.x. View

Pompili M, Serafini G, Di Cosimo D, Dominici G, Innamorati M, Lester D . Psychiatric comorbidity and suicide risk in patients with chronic migraine. Neuropsychiatr Dis Treat. 2010; 6:81-91. PMC: 2854084. DOI: 10.2147/ndt.s8467. View

Bellini B, Arruda M, Cescut A, Saulle C, Persico A, Carotenuto M . Headache and comorbidity in children and adolescents. J Headache Pain. 2013; 14:79. PMC: 3849985. DOI: 10.1186/1129-2377-14-79. View

10.

Seo J, Cho Y, Lee S, Lee J, Kim J, Moon H . Validation of the generalized anxiety disorder-7 in people with epilepsy: a MEPSY study. Epilepsy Behav. 2014; 35:59-63. DOI: 10.1016/j.yebeh.2014.04.005. View

11.

Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, Weiller E . The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1999; 59 Suppl 20:22-33;quiz 34-57. View

12.

Sareen J, Jacobi F, Cox B, Belik S, Clara I, Stein M . Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions. Arch Intern Med. 2006; 166(19):2109-16. DOI: 10.1001/archinte.166.19.2109. View

13.

Merikangas K, Angst J, Isler H . Migraine and psychopathology. Results of the Zurich cohort study of young adults. Arch Gen Psychiatry. 1990; 47(9):849-53. DOI: 10.1001/archpsyc.1990.01810210057008. View

14.

Zis P, Gatzonis S . Estimating the diagnostic value of the Neurological Disorders Depression Inventory for Epilepsy in different languages. Epilepsia. 2014; 55(6):941. DOI: 10.1111/epi.12609. View

15.

Hung C, Wang S, Yang C, Liu C . The impacts of migraine, anxiety disorders, and chronic depression on quality of life in psychiatric outpatients with major depressive disorder. J Psychosom Res. 2008; 65(2):135-42. DOI: 10.1016/j.jpsychores.2008.04.011. View

16.

Kim S, Park S . The role of headache chronicity among predictors contributing to quality of life in patients with migraine: a hospital-based study. J Headache Pain. 2014; 15:68. PMC: 4194437. DOI: 10.1186/1129-2377-15-68. View

17.

Spitzer R, Kroenke K, Williams J, Lowe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-7. DOI: 10.1001/archinte.166.10.1092. View

18.

. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33(9):629-808. DOI: 10.1177/0333102413485658. View

19.

Kosinski M, Bayliss M, Bjorner J, Ware Jr J, Garber W, Batenhorst A . A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res. 2003; 12(8):963-74. DOI: 10.1023/a:1026119331193. View

20.

Hamelsky S, Lipton R, Stewart W . An assessment of the burden of migraine using the willingness to pay model. Cephalalgia. 2005; 25(2):87-100. DOI: 10.1111/j.1468-2982.2005.00797.x. View